Metabotropic glutamate receptors and neurodegenerative diseases

FM Ribeiro, LB Vieira, RGW Pires, RP Olmo… - Pharmacological …, 2017 - Elsevier
Glutamate is the most important excitatory neurotransmitter of the mammalian central
nervous system (CNS), playing an important role in memory, synaptic plasticity and neuronal …

The extracellular signal-regulated kinase 1/2 pathway in neurological diseases: A potential therapeutic target

J Sun, G Nan - International journal of molecular …, 2017 - spandidos-publications.com
Signaling pathways are critical modulators of a variety of physiological and pathological
processes, and the abnormal activation of some signaling pathways can contribute to …

[HTML][HTML] Treatment of Huntington's disease

S Frank - Neurotherapeutics, 2014 - Elsevier
Huntington's disease (HD) is a dominantly inherited progressive neurological disease
characterized by chorea, an involuntary brief movement that tends to flow between body …

Regulation of GPCR activity, trafficking and localization by GPCR‐interacting proteins

AC Magalhaes, H Dunn… - British journal of …, 2012 - Wiley Online Library
GPCRs represent the largest family of integral membrane proteins and were first identified
as receptor proteins that couple via heterotrimeric G‐proteins to regulate a vast variety of …

Selective expression of mutant huntingtin during development recapitulates characteristic features of Huntington's disease

AE Molero, EE Arteaga-Bracho, CH Chen… - Proceedings of the …, 2016 - pnas.org
Recent studies have identified impairments in neural induction and in striatal and cortical
neurogenesis in Huntington's disease (HD) knock-in mouse models and associated …

Metabotropic glutamate receptor 5 knockout reduces cognitive impairment and pathogenesis in a mouse model of Alzheimer's disease

A Hamilton, JL Esseltine, RA DeVries, SP Cregan… - Molecular brain, 2014 - Springer
Background Alzheimer's disease (AD) pathology occurs in part as the result of excessive
production of β-amyloid (Aβ). Metabotropic glutamate receptor 5 (mGluR5) is now …

Group I metabotropic glutamate receptor signalling and its implication in neurological disease

F M. Ribeiro, M Paquet, S P. Cregan… - CNS & Neurological …, 2010 - benthamdirect.com
Stimulation of Group I metabotropic glutamate receptors (mGluR1 and mGluR5) leads to
activation of a wide variety of signalling pathways. mGluRs couple to Gαq/11 proteins …

International union of basic and clinical pharmacology. CXI. Pharmacology, signaling, and physiology of metabotropic glutamate receptors

KJ Gregory, C Goudet - Pharmacological reviews, 2021 - Elsevier
Metabotropic glutamate (mGlu) receptors respond to glutamate, the major excitatory
neurotransmitter in the mammalian brain, mediating a modulatory role that is critical for …

[HTML][HTML] Studying neurodegenerative diseases in culture models

J Schlachetzki, SW Saliba, ACP Oliveira - Brazilian Journal of …, 2013 - SciELO Brasil
Neurodegenerative diseases are pathological conditions that have an insidious onset and
chronic progression. Different models have been established to study these diseases in …

Involvement of metabotropic glutamate receptor 5, AKT/PI3K signaling and NF-κB pathway in methamphetamine-mediated increase in IL-6 and IL-8 expression in …

A Shah, PS Silverstein, DP Singh, A Kumar - Journal of neuroinflammation, 2012 - Springer
Methamphetamine (MA) is one of the commonly used illicit drugs and the central nervous
system toxicity of MA is well documented. The mechanisms contributing to this toxicity have …